Under 30’s Will Be Offered an Alternative Vaccine to Oxford-AstraZeneca

By Aiyana Lowry


An alternative vaccine to the Oxford-AstraZeneca will be offered to under 30-year-olds as evidence emerges that there could be a link between the jab and blood clots.


The recommendation for the alternative vaccine came after a review by the UK drugs regulator which found that by the end of march a total of 79 people suffered from rare blood clots after their vaccination and 19 of these people died.


Boris Johnson, the Prime Minister said the AstraZeneca vaccine has already saved thousands of lives; and the people of all ages should continue to have full confidence in vaccines; with the new advice.


The Medicines and Healthcare products Regulatory Agency (MHRA) found that 79 people suffering from blood clots and 19 people dying was after 20 million doses were administered. This means that the risk of developing a blood clot is four in one million and the risk of dying is one in a million. Out of the people who died they were aged between 18 and 79, with three of them aged under 30.


Although the regulator said there is not proof that the vaccination caused the blood clots.


Adam Simmons, 28 who had the Oxford-AstraZeneca vaccine said: “The concerns I had taking it was the reported side effects.” Furtherly adding: “I said to them when I took the vaccine that if I have any blood clotting then action will be taken to take them to court as its costing lives.”


Josie Kavanagh, 21 who had the Pfizer vaccine said: “A lot of my friends and family have had the AstraZeneca vaccine and have had no awful side effects nor any blood clots.”


Despite the concerns for blood clotting from the vaccine. Health Secretary Matt Hancock said the UK’s review on the Oxford-AstraZeneca vaccine is safe, effective and the benefits far outweigh the risks for the vast majority of adults. 


Also, that the UK is on track to vaccinate all adults by 31 July.

40 views0 comments